Finding risks for glaucoma

Editorial

. 2008 Aug;126(8):1138-9.

doi: 10.1001/archopht.126.8.1138.

Editorial

James D Brandt. Arch Ophthalmol. 2008 Aug.

. 2008 Aug;126(8):1138-9.

doi: 10.1001/archopht.126.8.1138.

No abstract available

Comment on

Canadian Glaucoma Study: 2. risk factors for the progression of open-angle glaucoma.
Chauhan BC, Mikelberg FS, Balaszi AG, LeBlanc RP, Lesk MR, Trope GE; Canadian Glaucoma Study Group. Chauhan BC, et al. Arch Ophthalmol. 2008 Aug;126(8):1030-6. doi: 10.1001/archopht.126.8.1030. Arch Ophthalmol. 2008. PMID: 18695095 Clinical Trial.

Signal/noise ratios to compare tests for measuring visual field progression.
Ernest PJ. Ernest PJ. Invest Ophthalmol Vis Sci. 2010 Dec;51(12):6893; author reply 6893-4. doi: 10.1167/iovs.10-5442. Invest Ophthalmol Vis Sci. 2010. PMID: 21123778 No abstract available.
Canadian Glaucoma Study: 2. risk factors for the progression of open-angle glaucoma.
Chauhan BC, Mikelberg FS, Balaszi AG, LeBlanc RP, Lesk MR, Trope GE; Canadian Glaucoma Study Group. Chauhan BC, et al. Arch Ophthalmol. 2008 Aug;126(8):1030-6. doi: 10.1001/archopht.126.8.1030. Arch Ophthalmol. 2008. PMID: 18695095 Clinical Trial.
Relation of glaucoma progression and myopia: the role of axial length.
Nowroozzadeh M. Nowroozzadeh M. Eur J Ophthalmol. 2009 Mar-Apr;19(2):327; author reply 327. doi: 10.1177/112067210901900231. Eur J Ophthalmol. 2009. PMID: 19253262 No abstract available.
Pathophysiology of the progressive optic neuropathy of glaucoma.
Levin LA. Levin LA. Ophthalmol Clin North Am. 2005 Sep;18(3):355-64, v. doi: 10.1016/j.ohc.2005.05.010. Ophthalmol Clin North Am. 2005. PMID: 16054993 Review.
Measuring rates of structural and functional change in glaucoma.
Nouri-Mahdavi K, Caprioli J. Nouri-Mahdavi K, et al. Br J Ophthalmol. 2015 Jul;99(7):893-8. doi: 10.1136/bjophthalmol-2014-305210. Epub 2014 Oct 6. Br J Ophthalmol. 2015. PMID: 25287369 Review.